John Finkle

John Finkle Email and Phone Number

Senior Vice President Safety And Pharmacovigilance @ BridgeBio

John Finkle's Contact Details

John Finkle personal email

n/a

John Finkle's Current Company Details

Bridgebio

Senior Vice President Safety And Pharmacovigilance

John Finkle Work Experience Details

  • Senior Vice President Patient Safety And Pharmacovigilance
    Bridgebio ['May 2022', 'Present']
    Palo Alto, California, Us
  • Vice President Safety And Pharmacovigilance
    Emergent Biosolutions ['Mar 2021', 'May 2022']
    Gaithersburg, Maryland, Us
    In my current role, I have global responsibility for the safety and pharmacovigilance of the EBSI portfolio. This includes leading all pre- and post-marketing safety, PV and risk management activities. Additionally, I directly manage several clinical development physicians.
  • Global Head, Pharma Safety
    Gsk ['Jan 2019', 'Mar 2021']
    Brentford, Middlesex, Gb
    At GSK, my leadership impacted all aspects of global safety evaluation and risk management for the entire early and late-stage development portfolio (all therapeutic areas), TESARO oncology portfolio, and Classic marketed products portfolio. Over 130 development compounds and medical products and a staff of over 140. Extensive experience with product in-license evaluations, co-development, acquisitions, and subsequent integration kept this job ever evolving and the activities were motivational to myself and my staff. I participated in many consortiums, steering committees and task forces that engaged the most pressing issues in the industry.
  • Global Head (Vp) Development Products
    Gsk ['Mar 2016', 'Dec 2018']
    Brentford, Middlesex, Gb
    I had global responsibility for all aspects of safety evaluation and risk management for GSK’s development portfolio ranging from pre-First Time in Human through early post marketing products for all therapeutic areas, and biologics. I created as served as Chair of the GSK Internal Cardiology Safety Panel and QT Advisory Panel from 2004-2021. These working panels suggested and advised on cardiovascular safety and QT evaluations for all compounds throughout GSK. These efforts lead to significant company-wide guidances for the management of cardiac safety in clinical trials as well as effective strategies for managing cardiac safety issues.
  • Head (Vp), Us Development Products, Safety Evaluation And Risk Management
    Gsk ['Jan 2011', 'Feb 2016']
    Brentford, Middlesex, Gb
    As the Global head , I spearheaded all aspects of safety evaluation and risk management for the Upper Providence and RTP sites for Global GSK development portfolio. Therapeutic areas include Oncology, Cardiovascular, Metabolic, Biopharm, GI/GU, Respiratory. During these 5 years, I often mentored in my department and others, growing junior member’s careers and performance capabilities, which continues to be a staple of my skill set.
  • Vice President Oncology Safety Evaluation And Risk Management
    Gsk ['Apr 2009', 'Dec 2011']
    Brentford, Middlesex, Gb
    Focusing on the Oncology Portfolio, I oversaw and further developed all aspects of Safety Evaluation and Risk Management for the Global GSK development and marketed Oncology Portfolio.
  • Cardiovascular Therapeutic Area Director
    Gsk ['Sep 2004', 'Mar 2009']
    Brentford, Middlesex, Gb
    Global responsibility for safety/pharmacovigilance of GSK cardiovascular and dyslipidemia development and marketed compounds. Managed physicians, scientists, and administrative support personnel. During this timeframe, I continued to Co-Chair the Cardiac Safety Research Consortium, up until 2017. This was a FDA-Duke University sponsored collaboration between the government, industry, and academic centers to promote cardiac safety while achieving enhanced timelines to accelerate medical product development. The main focus was to provide a collaborative setting for conduct of safety related research. I participated as a founding member of the Consortium that worked with all of the stakeholders to create an overall structure and governance process for the Group, including coordination of collaborative research projects, expanding the role of the consortium, coordinating activities with FDA, organizing various public Think Tanks held at FDA White Oak and other facilities, and acting as a liaison to other professional groups such as the International Society of Cardio Oncology, Health and Environmental Science Institute (HESI), DIA and others. I also co-led the effort to create industry wide cardiovascular CRF forms to be used in non-CV studies.
  • Director, Medical Review Group, Global Clinical Safety And Pharmacovigilance
    Gsk ['Jan 2003', 'Aug 2004']
    Brentford, Middlesex, Gb
  • Attending Physician And Partner
    Cardiovascular Associates Of Southeast Pennsylvania ['Jul 1999', 'Dec 2002']
  • Attending Physician
    Florida Heart Group ['Jun 1997', 'Jun 1999']

John Finkle Education Details

  • New York Medicine Jobs
    Doctor Of Medicine - Md
  • Tufts University
    Biology
  • University Of Pennsylvania
    Internal Medicine
  • Yale School Of Medicine
    Clinical Cardiac Electrophysiology

Other Similar Profiles

View similar profiles

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.

Frequently Asked Questions about John Finkle

What company does John Finkle work for?

John Finkle works for Bridgebio

What is John Finkle's role in his/her workplace?

John Finkle's role in his/her workplace is Senior Vice President Safety And Pharmacovigilance.

What is John Finkle's email address?

John Finkle's email address is jo****@****ons.com

What schools did John Finkle attend?

John Finkle attended New York Medicine Jobs, Tufts University, University Of Pennsylvania, and Yale School Of Medicine .

What are some of John Finkle's interests?

John Finkle has interest in Science And Technology.

What is John Finkle's role in his/her workplace?

John Finkle has skills like Pharmacovigilance, Pharmaceutical Industry, Clinical Research, Clinical Trials, Drug Development, Life Sciences, Clinical Development, and Oncology.

Who are the industry peers of John Finkle at other companies?

John Finkle's peers at other companies are Lisa Ciciretto, Bsn, Rn, Mike Monteith, Gary Bloomgren, Henry Jacotin, Pari Nasseri-Sina Msc Phd, and Mary Beth Sabol. and Ellen Gold. John Finkle's peers at other companies are Lisa Ciciretto, Bsn, Rn, Mike Monteith, Gary Bloomgren, Henry Jacotin, Pari Nasseri-Sina Msc Phd, and Mary Beth Sabol. and Ellen Gold.